Clinical Comparison of Influenza A and B Virus Infection in Hospitalized Children.
10.14776/piv.2017.24.1.23
- Author:
Seungwon JUNG
1
;
Joon Hee LEE
;
Jin Han KANG
;
Hak Sung LEE
;
Jae Won CHOI
;
Sang Hyuk MA
;
Jaywon LEE
Author Information
1. Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, the Republic of Korea.
- Publication Type:Original Article
- Keywords:
Influenza, human;
Oseltamivir
- MeSH:
Child;
Child, Hospitalized*;
Demography;
Fever;
Gyeongsangnam-do;
Herpesvirus 1, Cercopithecine*;
Humans;
Influenza, Human*;
Medical Records;
Oseltamivir;
Retrospective Studies;
Seasons
- From:Pediatric Infection & Vaccine
2017;24(1):23-30
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The objective of this study was to compare the clinical characteristics of influenza A and B infections and analyze the effect of oseltamivir in hospitalized children. METHODS: We investigated children under the age of 15, who were diagnosed with influenza A/H1N1, A/H3N2, or B from January to April 2014. The subjects were admitted to the Changwon Fatima Hospital and diagnosed using a rapid antigen test from nasopharyngeal swabs. The medical records of the patients were retrospectively reviewed. RESULTS: A total of 302 pediatric patients with influenza were enrolled. Influenza B infection was the most common type (n=187, 61.9%), followed by A/H3N2 (n=100, 33.1%) and A/H1N1 (n=15, 5.0%). Compared to patients diagnosed with influenza A, patients diagnosed with influenza B were older (P=0.005), and the duration of fever was significantly longer (P=0.001). A total of 161 patients (53.3%) had been vaccinated against influenza during the season, before admission. Among the patients infected with A/H3N2 and B, the duration of fever was shorter in oseltamivir recipients compared to oseltamivir non-recipients (P=0.026 and P=0.004, respectively). CONCLUSIONS: There were significant differences between influenza A and B groups in terms of age, demographics, and clinical course. Although the effectiveness of oseltamivir on influenza differs according to the type of influenza, our data provides evidence that oseltamivir is beneficial for both A and B infections.
